Endo International Q1 Loss Narrows

Endo International plc reported that its net loss for the first-quarter ended March 31, 2023 narrowed to $3.28 million or $0.01 per share from $71.97 million or $0.

Related Keywords

,Endo International ,Generic Pharmaceuticals ,Sterile Injectables ,Arnings For Stocks ,